Retinal angiomatous proliferation.

[1]  H. Kim,et al.  Long-term visual outcome and prognostic factors of Intravitreal anti-vascular endothelial growth factor treatment for retinal angiomatous proliferation , 2015, Graefe's Archive for Clinical and Experimental Ophthalmology.

[2]  F. Allievi,et al.  INTRAVITREAL BEVACIZUMAB AS PRIMARY TREATMENT FOR RETINAL ANGIOMATOUS PROLIFERATION: Twelve-Month Results , 2009, Retina.

[3]  A. Kampik,et al.  Intravitreal triamcinolone and laser photocoagulation for retinal angiomatous proliferation , 2006, British Journal of Ophthalmology.

[4]  T. Iida,et al.  Two-year results of combined intravitreal ranibizumab and photodynamic therapy for retinal angiomatous proliferation , 2015, Japanese Journal of Ophthalmology.

[5]  Glenn J Jaffe,et al.  Intravitreal aflibercept injection for neovascular age-related macular degeneration: ninety-six-week results of the VIEW studies. , 2014, Ophthalmology.

[6]  M. C. Donati,et al.  Retinal Angiomatous Proliferation: Association with Clinical and Angiographic Features , 2005, Ophthalmologica.

[7]  F. Viola,et al.  Sequential combined treatment with intravitreal bevacizumab and photodynamic therapy for retinal angiomatous proliferation , 2010, Eye.

[8]  Michael D. Ober,et al.  Sequenced combined intravitreal triamcinolone and indocyanine green angiography-guided photodynamic therapy for retinal angiomatous proliferation. , 2006, Archives of ophthalmology.

[9]  Y. Teo,et al.  Corrigendum: New loci and coding variants confer risk for age-related macular degeneration in East Asians , 2015, Nature Communications.

[10]  M. Yuzawa,et al.  Clinicopathological findings of retinal angiomatous proliferation , 2007, Graefe's Archive for Clinical and Experimental Ophthalmology.

[11]  A. Scott,et al.  Retinal angiomatous proliferation or retinal anastomosis to the lesion , 2010, Eye.

[12]  G. Staurenghi,et al.  RETINAL ANGIOMATOUS PROLIFERATION: Natural History and Progression of Visual Loss , 2009, Retina.

[13]  Timothy L. Jackson,et al.  Epimacular brachytherapy for the treatment of retinal angiomatous proliferation. , 2012, Retinal cases & brief reports.

[14]  F. Boscia,et al.  Photodynamic therapy with verteporfin for retinal angiomatous proliferation , 2006, Graefe's Archive for Clinical and Experimental Ophthalmology.

[15]  Hisashi Yamada,et al.  Clinical Ophthalmology Dovepress Retinal Angiomatous Proliferation Associated with Risk Alleles of Arms2/htra1 Gene Polymorphisms in Japanese Patients , 2022 .

[16]  P. Mitchell,et al.  Clinical risk factors for age-related macular degeneration: a systematic review and meta-analysis , 2010, BMC ophthalmology.

[17]  K. Bartz-Schmidt,et al.  Clinicopathological correlation of deep retinal vascular anomalous complex in age related macular degeneration , 2000, The British journal of ophthalmology.

[18]  Yara T. E. Lechanteur,et al.  Environmental and genetic risk factors for retinal angiomatous proliferation , 2014, Acta ophthalmologica.

[19]  N Orzalesi,et al.  Laser treatment of feeder vessels in subfoveal choroidal neovascular membranes: a revisitation using dynamic indocyanine green angiography. , 1998, Ophthalmology.

[20]  M. Costa,et al.  RETINAL ANGIOMATOUS PROLIFERATION: A Quantitative Analysis of the Fundoscopic Features of the Fellow Eye , 2015, Retina.

[21]  L. Pierro,et al.  Optical coherence tomography (OCT) in retinal angiomatous proliferation (RAP). , 2002, European journal of ophthalmology.

[22]  I. Maruko,et al.  Clinical characteristics of exudative age-related macular degeneration in Japanese patients. , 2007, American journal of ophthalmology.

[23]  K Bailey Freund,et al.  OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY OF TYPE 3 NEOVASCULARIZATION SECONDARY TO AGE-RELATED MACULAR DEGENERATION , 2015, Retina.

[24]  A. Tsujikawa,et al.  One-year result of aflibercept treatment on age-related macular degeneration and predictive factors for visual outcome. , 2015, American journal of ophthalmology.

[25]  Jesse J. Jung,et al.  TYPE 3 NEOVASCULARIZATION: Evolution, Association With Pigment Epithelial Detachment, and Treatment Response as Revealed by Spectral Domain Optical Coherence Tomography , 2015, Retina.

[26]  Christian Simader,et al.  Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration. , 2012, Ophthalmology.

[27]  S. Bearelly,et al.  The role of dynamic indocyanine green angiography in the diagnosis and treatment of retinal angiomatous proliferation , 2007, British Journal of Ophthalmology.

[28]  M. Díaz-Llopis,et al.  [Intravitreal injection of bevacizumab (Avastin) for retinal angiomatous proliferation]. , 2008, Archivos de la Sociedad Espanola de Oftalmologia.

[29]  F. Shiraga,et al.  Comparison of intravitreal triamcinolone acetonide with photodynamic therapy and intravitreal bevacizumab with photodynamic therapy for retinal angiomatous proliferation. , 2010, American journal of ophthalmology.

[30]  H. Oyamada,et al.  SUBFOVEAL CHOROIDAL THICKNESS CHANGES AFTER INTRAVITREAL RANIBIZUMAB AND PHOTODYNAMIC THERAPY FOR RETINAL ANGIOMATOUS PROLIFERATION , 2015, Retina.

[31]  J. Cunha-Vaz,et al.  Chorioretinal anastomosis and photodynamic therapy:a two-year follow-up study , 2007, Graefe's Archive for Clinical and Experimental Ophthalmology.

[32]  A. Negi,et al.  Effect of photodynamic therapy (PDT), posterior subtenon injection of triamcinolone acetonide with PDT, and intravitreal injection of ranibizumab with PDT for retinal angiomatous proliferation , 2012, Clinical ophthalmology.

[33]  M. Dunbar,et al.  Retinal angiomatous proliferation: clinical characteristics and treatment options. , 2004, Optometry.

[34]  J. Montero,et al.  Efficacy of Intravitreal Bevacizumab to Treat Retinal Angiomatous Proliferation Stage II and III , 2009, European journal of ophthalmology.

[35]  C. Costagliola,et al.  Intravitreal bevacizumab for the treatment of retinal angiomatous proliferation. , 2007, American journal of ophthalmology.

[36]  S. Baltatzis,et al.  Photodynamic Therapy in Retinal Angiomatous Proliferation Stage I , 2006, European journal of ophthalmology.

[37]  Haoyu Chen,et al.  Association of Genetic Variants with Polypoidal Choroidal Vasculopathy: A Systematic Review and Updated Meta-analysis. , 2015, Ophthalmology.

[38]  T. Iida,et al.  Two-year results of combined intravitreal anti-VEGF agents and photodynamic therapy for retinal angiomatous proliferation , 2013, Japanese Journal of Ophthalmology.

[39]  M. Maier,et al.  Therapie der retinalen angiomatösen Proliferation im Stadium III , 2013, Der Ophthalmologe.

[40]  S. Kishi,et al.  TOMOGRAPHIC FEATURES OF INTRARETINAL NEOVASCULARIZATION IN RETINAL ANGIOMATOUS PROLIFERATION , 2010, Retina.

[41]  P. Campochiaro,et al.  Transgenic mice with increased expression of vascular endothelial growth factor in the retina: a new model of intraretinal and subretinal neovascularization. , 1997, The American journal of pathology.

[42]  F. Boscia,et al.  Photodynamic therapy for retinal angiomatous proliferations and pigment epithelium detachment. , 2004, American journal of ophthalmology.

[43]  Young Gun Park,et al.  One year results of intravitreal ranibizumab monotherapy for retinal angiomatous proliferation: a comparative analysis based on disease stages , 2015, BMC Ophthalmology.

[44]  P. Keane,et al.  Long-term visual and anatomical outcomes following anti-VEGF monotherapy for retinal angiomatous proliferation , 2009, British Journal of Ophthalmology.

[45]  Jae Hui Kim,et al.  Fellow‐eye neovascularization in unilateral retinal angiomatous proliferation in a Korean population , 2016, Acta ophthalmologica.

[46]  L. Pierro,et al.  Optical coherence tomography (OCT) angiomatous prolifieration (RAP) in retinal. , 2002, European journal of ophthalmology.

[47]  A. Joussen,et al.  Bevacizumab (Avastin) treatment in patients with retinal angiomatous proliferation , 2007, Graefe's Archive for Clinical and Experimental Ophthalmology.

[48]  N. Lois,et al.  Combined therapy for retinal angiomatous proliferation with intravitreal triamcinolone and argon laser photocoagulation , 2008, British Journal of Ophthalmology.

[49]  J. Tiedeman,et al.  Intravitreal Bevacizumab (Avastin®) in the Treatment of Retinal Angiomatous Proliferation , 2007 .

[50]  R. Steigerwalt,et al.  Retinal Angiomatous Proliferation Successfully Treated with Indocyanine Green Dye-Enhanced Photocoagulation. , 2013, Ophthalmic surgery, lasers & imaging : the official journal of the International Society for Imaging in the Eye.

[51]  W. Lee,et al.  COMBINATION THERAPY OF RANIBIZUMAB AND PHOTODYNAMIC THERAPY FOR RETINAL ANGIOMATOUS PROLIFERATION WITH SEROUS PIGMENT EPITHELIAL DETACHMENT IN KOREAN PATIENTS: Twelve-Month Results , 2011, Retina.

[52]  L A Yannuzzi,et al.  Retinal choroidal anastomoses and occult choroidal neovascularization in age-related macular degeneration. , 2000, Ophthalmology.

[53]  R. Zawadzki,et al.  HIGH RESOLUTION FOURIER-DOMAIN OPTICAL COHERENCE TOMOGRAPHY OF RETINAL ANGIOMATOUS PROLIFERATION , 2007, Retina.

[54]  M. Abraldes,et al.  Successful Treatment of Retinal Angiomatous Proliferation by Photodynamic Therapy , 2006, Optometry and vision science : official publication of the American Academy of Optometry.

[55]  K. Matsuo,et al.  CFH and ARMS2 variations in age-related macular degeneration, polypoidal choroidal vasculopathy, and retinal angiomatous proliferation. , 2010, Investigative ophthalmology & visual science.

[56]  D. Roth,et al.  MICROPULSED LASER PHOTOCOAGULATION AND INTRAVITREAL TRIAMCINOLONE ACETONIDE INJECTION FOR THE TREATMENT OF RETINAL ANGIOMATOUS PROLIFERATION , 2007, Retina.

[57]  A. Elsner,et al.  Deep retinal vascular anomalous complexes in advanced age-related macular degeneration. , 1996, Ophthalmology.

[58]  L. Yannuzzi,et al.  Review of retinal angiomatous proliferation or type 3 neovascularization. , 2008, Retina.

[59]  G. Soubrane,et al.  Imaging of chorioretinal anastomoses in vascularized retinal pigment epithelium detachments. , 1995, Archives of ophthalmology.

[60]  M. Nicolò,et al.  Retinal angiomatous proliferation treated by intravitreal triamcinolone and photodynamic therapy with verteporfin , 2006, Graefe's Archive for Clinical and Experimental Ophthalmology.

[61]  G. Lo Giudice,et al.  SINGLE-SESSION PHOTODYNAMIC THERAPY COMBINED WITH INTRAVITREAL BEVACIZUMAB FOR RETINAL ANGIOMATOUS PROLIFERATION , 2008, Retina.

[62]  G. Ying,et al.  Outcomes in Eyes with Retinal Angiomatous Proliferation in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT). , 2016, Ophthalmology.

[63]  J. García-Feijóo,et al.  Retinal Angiomatous Proliferation Reactivation 6 Months after High-Dose Intravitreal Acetonide Triamcinolone and Photodynamic Therapy , 2007, European journal of ophthalmology.

[64]  N. Eter,et al.  Retinal Pigment Epithelium Tears: Risk Factors, Mechanism and Therapeutic Monitoring , 2015, Ophthalmologica.

[65]  M. Yuzawa,et al.  Surgical excision of neovascularization in retinal angiomatous proliferation , 2005, Graefe's Archive for Clinical and Experimental Ophthalmology.

[66]  N. Yoshimura,et al.  Rapidly progressive scar formation after transpupillary thermotherapy in retinal angiomatous proliferation. , 2003, Retina.

[67]  C. Glittenberg,et al.  Retinal angiomatous proliferation: morphological changes assessed by Stratus and Cirrus OCT. , 2009, Ophthalmic surgery, lasers & imaging : the official journal of the International Society for Imaging in the Eye.

[68]  Gabriëlle H S Buitendijk,et al.  Seven New Loci Associated with Age-Related Macular Degeneration , 2013, Nature Genetics.

[69]  J. Weiter,et al.  Classification of retinal pigment epithelial detachments associated with drusen , 2004, Graefe's Archive for Clinical and Experimental Ophthalmology.

[70]  F. Shiraga,et al.  RECURRENCE AFTER SURGICAL ABLATION FOR RETINAL ANGIOMATOUS PROLIFERATION , 2007, Retina.

[71]  E. Cervera,et al.  Inyección intravítrea de Bevacizumab (Avastin®) para profileración angiomatosa retiniana , 2008 .

[72]  Yong-Kyu Kim,et al.  CHOROIDAL THICKNESS CHANGE AFTER INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT IN RETINAL ANGIOMATOUS PROLIFERATION AND ITS RECURRENCE , 2016, Retina.

[73]  J. Townend,et al.  GEOGRAPHIC ATROPHY IN RETINAL ANGIOMATOUS PROLIFERATION , 2011, Retina.

[74]  F. Shiraga,et al.  One-year results of bevacizumab intravitreal and posterior sub-Tenon injection of triamcinolone acetonide with reduced laser fluence photodynamic therapy for retinal angiomatous proliferation , 2012, Japanese Journal of Ophthalmology.

[75]  H. Koizumi,et al.  Choroidal circulatory disturbances associated with retinal angiomatous proliferation on indocyanine green angiography , 2008, Graefe's Archive for Clinical and Experimental Ophthalmology.

[76]  Johanna M Seddon,et al.  Potential public health impact of Age-Related Eye Disease Study results: AREDS report no. 11. , 2003, Archives of ophthalmology.

[77]  Gerald Seidel,et al.  Combination treatment of photodynamic therapy with verteporfin and intravitreal ranibizumab in patients with retinal angiomatous proliferation , 2013, Acta ophthalmologica.

[78]  Christian Simader,et al.  Pigment epithelial detachment followed by retinal cystoid degeneration leads to vision loss in treatment of neovascular age-related macular degeneration. , 2015, Ophthalmology.

[79]  K Bailey Freund,et al.  MULTIMODAL IMAGING OF PIGMENT EPITHELIAL DETACHMENT: A Guide to Evaluation , 2013, Retina.

[80]  K. Kadonosono,et al.  Long-term results of intravitreal ranibizumab for the treatment of retinal angiomatous proliferation and utility of an advanced RPE analysis performed using spectral-domain optical coherence tomography , 2014, British Journal of Ophthalmology.

[81]  W. Lee,et al.  Combined intravitreal ranibizumab and photodynamic therapy for retinal angiomatous proliferation. , 2012, American journal of ophthalmology.

[82]  C. Cheung,et al.  Age-related macular degeneration and polypoidal choroidal vasculopathy in Asians , 2016, Progress in Retinal and Eye Research.

[83]  H. Kim,et al.  Risk factors for geographic atrophy after intravitreal ranibizumab injections for retinal angiomatous proliferation. , 2015, American journal of ophthalmology-glaucoma.

[84]  R. Spaide,et al.  Retinal vascular layers imaged by fluorescein angiography and optical coherence tomography angiography. , 2015, JAMA ophthalmology.

[85]  W. März,et al.  Association of complement factor H Y402H gene polymorphism with different subtypes of exudative age-related macular degeneration. , 2007, Ophthalmology.

[86]  A. Agarwal,et al.  Focal Inner Retinal Hemorrhages in Patients with Drusen: An Early Sign of Occult Choroidal Neovascularization and Chorioretinal Anastomosis , 2003, Retina.

[87]  E. Chew,et al.  Retinal angiomatous proliferation complicated by pigment epithelial tear following intravitreal bevacizumab treatment. , 2008, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie.

[88]  H. Helbig,et al.  Visual and morphological outcomes of bevacizumab (Avastin®) versus ranibizumab (Lucentis®) treatment for retinal angiomatous proliferation , 2012, International Ophthalmology.

[89]  Yoosoo Chang,et al.  Age-related macular degeneration in a screened South Korean population: prevalence, risk factors, and subtypes. , 2009, Ophthalmic epidemiology.

[90]  K. Tsaousis,et al.  Intravitreal aflibercept treatment of retinal angiomatous proliferation: a pilot study and short-term efficacy , 2015, Graefe's Archive for Clinical and Experimental Ophthalmology.

[91]  A. Rouvas,et al.  Angiographic and OCT features of retinal angiomatous proliferation , 2010, Eye.

[92]  Feng Wen,et al.  New loci and coding variants confer risk for age-related macular degeneration in East Asians , 2015, Nature Communications.

[93]  D. Sarraf,et al.  TEARS OF THE RETINAL PIGMENT EPITHELIUM: An Old Problem in a New Era , 2007, Retina.

[94]  E. Souied,et al.  Three dimensional spectral domain optical coherence tomography features of retinal–choroidal anastomosis , 2011, Graefe's Archive for Clinical and Experimental Ophthalmology.

[95]  S. J. Talks,et al.  Anatomical and visual outcome of retinal angiomatous proliferation treated with photodynamic therapy and intravitreal triamcinolone. , 2007, American journal of ophthalmology.

[96]  Johannes F de Boer,et al.  Phase-Resolved Doppler Optical Coherence Tomographic Features in Retinal Angiomatous Proliferation. , 2015, American journal of ophthalmology.

[97]  J. García-Feijóo,et al.  Ranibizumab in Retinal Angiomatous Proliferation (RAP): Influence of RAP Stage on Visual Outcome , 2011, European journal of ophthalmology.

[98]  I. Mantel,et al.  Retinal Angiomatous Proliferation Treated with a Combination of Intravitreal Triamcinolone Acetonide and Photodynamic Therapy with Verteporfin , 2006, European journal of ophthalmology.

[99]  J. Slakter,et al.  INTRAVITREAL BEVACIZUMAB (AVASTIN) FOR RETINAL ANGIOMATOUS PROLIFERATION , 2007, Retina.

[100]  J. Federman,et al.  Surgical ablation of retinal angiomatous proliferation. , 2003, Archives of ophthalmology.

[101]  S. Harding,et al.  Incidence of neovascularization in the fellow eye of patients with unilateral retinal angiomatous proliferation , 2010, Eye.

[102]  J. Mateos,et al.  [Treatment of retinal angiomatous proliferation (RAP). A retrospective study]. , 2007, Archivos de la Sociedad Espanola de Oftalmologia.

[103]  Glenn J Jaffe,et al.  Growth of geographic atrophy in the comparison of age-related macular degeneration treatments trials. , 2015, Ophthalmology.

[104]  David J. Wilson,et al.  Clinicopathologic correlation of retinal angiomatous proliferation. , 2008, Archives of ophthalmology.

[105]  C. Kramann,et al.  Intravitreal ranibizumab treatment of retinal angiomatous proliferation , 2012, Acta ophthalmologica.

[106]  G. Staurenghi,et al.  Treatment of retinal angiomatous proliferation in age-related macular degeneration: a series of 104 cases of retinal angiomatous proliferation. , 2005, Archives of ophthalmology.

[107]  K Bailey Freund,et al.  Optical coherence tomography angiography of type 3 neovascularisation in age-related macular degeneration after antiangiogenic therapy , 2016, British Journal of Ophthalmology.

[108]  F. Menchini,et al.  Intravitreal bevacizumab versus ranibizumab for the treatment of retinal angiomatous proliferation , 2013, Acta ophthalmologica.

[109]  F. Wen,et al.  Subtype lesions of neovascular age-related macular degeneration in Chinese patients , 2007, Graefe's Archive for Clinical and Experimental Ophthalmology.

[110]  M. Yuzawa,et al.  Combining surgical ablation of retinal inflow and outflow vessels with photodynamic therapy for retinal angiomatous proliferation. , 2006, American journal of ophthalmology.

[111]  K. Freund,et al.  En face OCT angiography demonstrates flow in early type 3 neovascularization (retinal angiomatous proliferation) , 2015, Eye.

[112]  K. Nishida,et al.  INCIDENCE AND CHARACTERISTICS OF NEOVASCULARIZATION IN FELLOW EYES OF JAPANESE PATIENTS WITH UNILATERAL RETINAL ANGIOMATOUS PROLIFERATION , 2014, Retina.

[113]  M. Sastre,et al.  Tratamiento de la proliferación angiomatosa retiniana (RAP). Estudio retrospectivo , 2007 .

[114]  M. Moschos,et al.  LONG-TERM RESULTS OF INTRAVITREAL RANIBIZUMAB, INTRAVITREAL RANIBIZUMAB WITH PHOTODYNAMIC THERAPY, AND INTRAVITREAL TRIAMCINOLONE WITH PHOTODYNAMIC THERAPY FOR THE TREATMENT OF RETINAL ANGIOMATOUS PROLIFERATION , 2012, Retina.

[115]  T. Iida,et al.  Angiographic results of retinal-retinal anastomosis and retinal-choroidal anastomosis after treatments in eyes with retinal angiomatous proliferation , 2012, Clinical ophthalmology.

[116]  Robert A. Linsenmeier,et al.  Oxygen distribution in the macaque retina. , 1993, Investigative ophthalmology & visual science.

[117]  J. Ruiz-Moreno,et al.  Efficacy of intravitreal and periocular triamcinolone associated with photodynamic therapy for treatment of retinal angiomatous proliferation , 2008, British Journal of Ophthalmology.

[118]  S. Kishi,et al.  TREAT-AND-EXTEND REGIMEN WITH AFLIBERCEPT FOR RETINAL ANGIOMATOUS PROLIFERATION , 2016, Retina.

[119]  M. Gharbiya,et al.  INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR FOR RETINAL ANGIOMATOUS PROLIFERATION IN TREATMENT-NAIVE EYES: Long-term Functional and Anatomical Results Using A Modified PrONTO-Style Regimen , 2014, Retina.

[120]  T. Desmettre,et al.  Types of choroidal neovascularisation in newly diagnosed exudative age-related macular degeneration , 2007, British Journal of Ophthalmology.

[121]  J. Slakter,et al.  RETINAL ANGIOMATOUS PROLIFERATION IN AGE–RELATED MACULAR DEGENERATION , 2001, Retina.

[122]  F. Bandello,et al.  The role of optical coherence tomography (OCT) in the diagnosis and management of retinal angiomatous proliferation (RAP) in patients with age-related macular degeneration. , 2006, Annals of the Academy of Medicine, Singapore.

[123]  H. Yu,et al.  OPTICAL COHERENCE TOMOGRAPHY–BASED RANIBIZUMAB MONOTHERAPY FOR RETINAL ANGIOMATOUS PROLIFERATION IN KOREAN PATIENTS , 2014, Retina.

[124]  J. W. Miller.  Vascular endothelial growth factor and ocular neovascularization. , 1997, The American journal of pathology.

[125]  T. Wong,et al.  Polypoidal Choroidal Vasculopathy in Asians , 2015, Journal of clinical medicine.

[126]  M. Maier,et al.  [Therapy of stage III retinal angiomatous proliferation. Intravitreal ranibizumab injections]. , 2013, Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft.

[127]  S. Harding,et al.  Early response of retinal angiomatous proliferation treated with intravitreal pegaptanib: a retrospective review , 2009, Eye.

[128]  J. Monés,et al.  Bimonthly half-dose ranibizumab in large pigment epithelial detachment and retinal angiomatous proliferation with high risk of retinal pigment epithelium tear: a case report , 2013, Clinical ophthalmology.

[129]  S. Kang,et al.  Thinner choroid and greater drusen extent in retinal angiomatous proliferation than in typical exudative age-related macular degeneration. , 2013, American journal of ophthalmology.

[130]  B. Glaser,et al.  FOCAL LASER ABLATION OF RETINAL ANGIOMATOUS PROLIFERATION , 2006, Retina.

[131]  S. Kinoshita,et al.  SUBFOVEAL CHOROIDAL THICKNESS IN RETINAL ANGIOMATOUS PROLIFERATION , 2014, Retina.

[132]  D. Weinberger,et al.  Angiographic and flow patterns of retinal choroidal anastomoses in age-related macular degeneration with occult choroidal neovascularization. , 2002, Ophthalmology.

[133]  L. Yannuzzi,et al.  NATURE AND RISK OF NEOVASCULARIZATION IN THE FELLOW EYE OF PATIENTS WITH UNILATERAL RETINAL ANGIOMATOUS PROLIFERATION , 2005, Retina.

[134]  Y. Tano,et al.  Recurrent retinal angiomatous proliferation after surgical ablation. , 2005, American journal of ophthalmology.

[135]  U. Schmidt-Erfurth,et al.  Histopathological changes following photodynamic therapy in human eyes. , 2002, Archives of ophthalmology.

[136]  F. Shiraga,et al.  Combined intravitreal bevacizumab and photodynamic therapy for retinal angiomatous proliferation. , 2012, American journal of ophthalmology.

[137]  L. Yannuzzi,et al.  TYPE 3 NEOVASCULARIZATION: The Expanded Spectrum of Retinal Angiomatous Proliferation , 2008, Retina.

[138]  K. Freund,et al.  “TREAT AND EXTEND” DOSING OF INTRAVITREAL ANTIVASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY FOR TYPE 3 NEOVASCULARIZATION/RETINAL ANGIOMATOUS PROLIFERATION , 2009, Retina.

[139]  P. Kertes,et al.  POTENTIAL PUBLIC HEALTH IMPACT OF AGE-RELATED EYE DISEASE STUDY RESULTS: AREDS REPORT NO. 11 , 2004 .